NASDAQ:ZYNE Archives - Market Exclusive

Home Tags NASDAQ:ZYNE

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

ME Staff - December 19, 2018

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

ME Staff - May 31, 2018

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

ME Staff - March 23, 2018

Analyst Activity – Ladenburg Thalmann Financial Services Initiates Coverage On Zynerba...

ME Staff - January 29, 2018

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

ME Staff - January 3, 2018

Biotech Movers: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) and PTC Therapeutics, Inc. (NASDAQ:PTCT)

ME Contributor - September 29, 2017

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Reports Third Quarter 2016...

ME Staff - November 14, 2016

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Announces Initiation of STAR...

ME Staff - November 2, 2016

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K

ME Staff - October 18, 2016

EDITOR PICKS

Cannabis Stock News Daily Roundup March 20

March 20, 2019

Market Morning: Fed Speaks, FedEx Falls, Starbucks Stars, Bayer In Trouble

March 20, 2019

Cannabis Stock News Daily Roundup March 19

March 19, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NASDAQ:ZYNE

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

Analyst Activity – Ladenburg Thalmann Financial Services Initiates Coverage On Zynerba...

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

Biotech Movers: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) and PTC Therapeutics, Inc. (NASDAQ:PTCT)

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Reports Third Quarter 2016...

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Announces Initiation of STAR...

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K

EDITOR PICKS

Cannabis Stock News Daily Roundup March 20

Market Morning: Fed Speaks, FedEx Falls, Starbucks Stars, Bayer In Trouble

Cannabis Stock News Daily Roundup March 19

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY